Diana Paleacu

Summary

Affiliation: Tel Aviv University
Country: Israel

Publications

  1. ncbi request reprint Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease
    Daniel Oved
    Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Mov Disord 21:1257-61. 2006
  2. ncbi request reprint Effects of pharmacological therapy on gait and cognitive function in depressed patients
    Diana Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, Israel
    Clin Neuropharmacol 30:63-71. 2007
  3. pmc Tetrabenazine in the treatment of Huntington's disease
    Diana Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Neuropsychiatr Dis Treat 3:545-51. 2007
  4. ncbi request reprint Olanzapine in Huntington's disease
    D Paleacu
    Neurological Service and Memory Clinic, Abarbanel Mental Health Center, Keren Kayemet, Bat Yam, Sackler School of Medicine, Tel Aviv University, Israel
    Acta Neurol Scand 105:441-4. 2002
  5. ncbi request reprint Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease
    Diana Paleacu
    Neurological Service and Memory Clinic, Abarbanel Mental Health Center, Sackler School of Medicine, Tel Aviv University, Bat Yam, Israel
    Clin Neuropharmacol 25:313-7. 2002
  6. ncbi request reprint Tetrabenazine treatment in movement disorders
    D Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, affiliated to the Sackler School of Medicine, Tel Aviv University, Israel
    Clin Neuropharmacol 27:230-3. 2004
  7. ncbi request reprint Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study
    D Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, Israel
    Int J Geriatr Psychiatry 23:393-400. 2008
  8. doi request reprint Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study
    Yoram Barak
    Abarbanel Mental Health Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Int Psychogeriatr 23:1515-9. 2011
  9. doi request reprint Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart review
    Shelly Tadger
    Abarbanel Mental Health Center, affiliated with the Sackler School of Medicine, Tel Aviv University, 15 KKL Street, Bat Yam, 59100 Israel
    Arch Gerontol Geriatr 53:104-5. 2011
  10. ncbi request reprint Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients
    Yoram Barak
    Abarbanel Mental Health Center, Bat Yam, Israel
    Am J Geriatr Psychiatry 15:354-6. 2007

Detail Information

Publications16

  1. ncbi request reprint Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease
    Daniel Oved
    Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Mov Disord 21:1257-61. 2006
    ..63 vs. 11.7 +/- 5.16; P < 0.05). Fatigue is prevalent in patients with PD but is not influenced by dopamine agonists. Somnolence cannot be attributed to the increase in fatigability and apparently involves a different mechanism...
  2. ncbi request reprint Effects of pharmacological therapy on gait and cognitive function in depressed patients
    Diana Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, Israel
    Clin Neuropharmacol 30:63-71. 2007
    ..To investigate the relationship among affective status, cognitive function, and gait in depressed patients and to evaluate the effects of treatment of depression on gait and cognitive function...
  3. pmc Tetrabenazine in the treatment of Huntington's disease
    Diana Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Neuropsychiatr Dis Treat 3:545-51. 2007
    ..This review emphasizes the advantage of TBZ over dopamine-depleting compounds used in the treatment of chorea and reveals its clinical efficacy and side effects...
  4. ncbi request reprint Olanzapine in Huntington's disease
    D Paleacu
    Neurological Service and Memory Clinic, Abarbanel Mental Health Center, Keren Kayemet, Bat Yam, Sackler School of Medicine, Tel Aviv University, Israel
    Acta Neurol Scand 105:441-4. 2002
    ..To study the effect of olanzapine (OL) in Huntington's disease (HD) patients...
  5. ncbi request reprint Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease
    Diana Paleacu
    Neurological Service and Memory Clinic, Abarbanel Mental Health Center, Sackler School of Medicine, Tel Aviv University, Bat Yam, Israel
    Clin Neuropharmacol 25:313-7. 2002
    ..Acetylcholinesterase inhibitors should be considered for the treatment of BPSD before neuroleptic treatment is instituted in AD patients with low levels of irritability and agitation...
  6. ncbi request reprint Tetrabenazine treatment in movement disorders
    D Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, affiliated to the Sackler School of Medicine, Tel Aviv University, Israel
    Clin Neuropharmacol 27:230-3. 2004
    ..4 +/- 21.3 months. The report concludes that TBZ is a moderately effective treatment of a large variety of hyperkinetic movement disorders, with excellent effects in a subgroup with chorea and facial dystonia/dyskinesias...
  7. ncbi request reprint Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study
    D Paleacu
    Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, Israel
    Int J Geriatr Psychiatry 23:393-400. 2008
    ..Quetiapine is an atypical antipsychotic agent that warrants further investigation...
  8. doi request reprint Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study
    Yoram Barak
    Abarbanel Mental Health Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Int Psychogeriatr 23:1515-9. 2011
    ..Escitalopram was investigated since citalopram has demonstrated some effectiveness in AD. We compared escitalopram and risperidone for psychotic symptoms and agitation associated with AD...
  9. doi request reprint Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart review
    Shelly Tadger
    Abarbanel Mental Health Center, affiliated with the Sackler School of Medicine, Tel Aviv University, 15 KKL Street, Bat Yam, 59100 Israel
    Arch Gerontol Geriatr 53:104-5. 2011
    ..Further prospective studies need be carried out to support our observation...
  10. ncbi request reprint Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients
    Yoram Barak
    Abarbanel Mental Health Center, Bat Yam, Israel
    Am J Geriatr Psychiatry 15:354-6. 2007
    ..To evaluate the rate of adverse medical outcomes for elderly exposed to antipsychotic treatment...
  11. ncbi request reprint Quetiapine for elderly non-responsive schizophrenia patients
    Doron Mazeh
    Abarbanel Mental Health Center, Tel Aviv University, Israel
    Psychiatry Res 157:265-7. 2008
    ..Four patients discontinued treatment due to clinical exacerbation or sedation. There was no increase in abnormal movements or body weight...
  12. ncbi request reprint Narcolepsy and psychotic states--a case report
    Yuval Melamed
    Lev Hasharon Mental Health Center, Netanya, Israel
    Isr J Psychiatry Relat Sci 46:70-3. 2009
    ..Multidisciplinary cooperation of neurologists and psychiatrists enabled this therapy to be administered for the patient's benefit...
  13. ncbi request reprint Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study
    D Mazeh
    Psychogeriatric Ward, Abarbanel Mental Health Center, Bat Yam and the Sackler School of Medicine, Tel Aviv University, Israel
    Int Psychogeriatr 18:429-36. 2006
    ..Donepezil inhibits cholinesterase, thus enhancing cholinergic neurotransmission. We tested the efficacy of donepezil in elderly patients with chronic schizophrenia and severe cognitive impairment...
  14. ncbi request reprint Association between family history of dementia and hallucinations in Parkinson disease
    Diana Paleacu
    Neurology Service and Memory Clinic, Yehuda Abarbanel Mental Health Center and Sackler Faculty of Medicine, Tel Aviv University, Israel
    Neurology 64:1712-5. 2005
    ..To identify familial risk factors for hallucinations in patients with Parkinson disease (PD)...
  15. ncbi request reprint Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease
    N Giladi
    Department of Neurology, Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Israel
    J Neural Transm 107:59-71. 2000
    ..To study the relationships between clinical features of Parkinson's disease (PD) and the development of dementia, depression or psychosis in patients with long-standing disease...
  16. ncbi request reprint Donepezil for the treatment of a schizophrenia patient with frontal lobotomy
    Doron Mazeh
    J Clin Psychopharmacol 23:522. 2003